16-3243888-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000541159.5(MEFV):​c.1306G>A​(p.Gly436Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.432 in 1,612,752 control chromosomes in the GnomAD database, including 153,596 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.41 ( 12998 hom., cov: 31)
Exomes 𝑓: 0.43 ( 140598 hom. )

Consequence

MEFV
ENST00000541159.5 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.206

Publications

41 publications found
Variant links:
Genes affected
MEFV (HGNC:6998): (MEFV innate immunity regulator, pyrin) This gene encodes a protein, also known as pyrin or marenostrin, that is an important modulator of innate immunity. Mutations in this gene are associated with Mediterranean fever, a hereditary periodic fever syndrome. [provided by RefSeq, Jul 2008]
MEFV Gene-Disease associations (from GenCC):
  • familial Mediterranean fever
    Inheritance: AD, AR, SD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, ClinGen
  • autosomal recessive familial Mediterranean fever
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • familial Mediterranean fever, autosomal dominant
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.046295E-4).
BP6
Variant 16-3243888-C-T is Benign according to our data. Variant chr16-3243888-C-T is described in ClinVar as Benign. ClinVar VariationId is 36505.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.457 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000541159.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
NM_000243.3
MANE Select
c.1764G>Ap.Pro588Pro
synonymous
Exon 9 of 10NP_000234.1
MEFV
NM_001198536.2
c.1306G>Ap.Gly436Arg
missense
Exon 8 of 9NP_001185465.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MEFV
ENST00000541159.5
TSL:1
c.1306G>Ap.Gly436Arg
missense
Exon 8 of 9ENSP00000438711.1
MEFV
ENST00000219596.6
TSL:1 MANE Select
c.1764G>Ap.Pro588Pro
synonymous
Exon 9 of 10ENSP00000219596.1
MEFV
ENST00000539145.5
TSL:1
n.*397G>A
non_coding_transcript_exon
Exon 6 of 7ENSP00000444471.1

Frequencies

GnomAD3 genomes
AF:
0.409
AC:
62069
AN:
151778
Hom.:
12999
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.338
Gnomad AMI
AF:
0.599
Gnomad AMR
AF:
0.375
Gnomad ASJ
AF:
0.436
Gnomad EAS
AF:
0.387
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.442
Gnomad MID
AF:
0.481
Gnomad NFE
AF:
0.461
Gnomad OTH
AF:
0.426
GnomAD2 exomes
AF:
0.392
AC:
98072
AN:
250496
AF XY:
0.396
show subpopulations
Gnomad AFR exome
AF:
0.341
Gnomad AMR exome
AF:
0.261
Gnomad ASJ exome
AF:
0.444
Gnomad EAS exome
AF:
0.378
Gnomad FIN exome
AF:
0.429
Gnomad NFE exome
AF:
0.459
Gnomad OTH exome
AF:
0.431
GnomAD4 exome
AF:
0.434
AC:
634285
AN:
1460856
Hom.:
140598
Cov.:
57
AF XY:
0.432
AC XY:
313647
AN XY:
726710
show subpopulations
African (AFR)
AF:
0.333
AC:
11130
AN:
33468
American (AMR)
AF:
0.272
AC:
12164
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.440
AC:
11508
AN:
26136
East Asian (EAS)
AF:
0.386
AC:
15331
AN:
39696
South Asian (SAS)
AF:
0.286
AC:
24670
AN:
86230
European-Finnish (FIN)
AF:
0.436
AC:
23214
AN:
53230
Middle Eastern (MID)
AF:
0.442
AC:
2548
AN:
5768
European-Non Finnish (NFE)
AF:
0.457
AC:
507896
AN:
1111288
Other (OTH)
AF:
0.428
AC:
25824
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
21658
43316
64973
86631
108289
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15010
30020
45030
60040
75050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.409
AC:
62086
AN:
151896
Hom.:
12998
Cov.:
31
AF XY:
0.404
AC XY:
30014
AN XY:
74204
show subpopulations
African (AFR)
AF:
0.338
AC:
13983
AN:
41414
American (AMR)
AF:
0.375
AC:
5723
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.436
AC:
1511
AN:
3468
East Asian (EAS)
AF:
0.388
AC:
1995
AN:
5148
South Asian (SAS)
AF:
0.272
AC:
1313
AN:
4824
European-Finnish (FIN)
AF:
0.442
AC:
4652
AN:
10520
Middle Eastern (MID)
AF:
0.497
AC:
145
AN:
292
European-Non Finnish (NFE)
AF:
0.461
AC:
31326
AN:
67952
Other (OTH)
AF:
0.424
AC:
893
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1894
3788
5683
7577
9471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
584
1168
1752
2336
2920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.438
Hom.:
40777
Bravo
AF:
0.400
TwinsUK
AF:
0.456
AC:
1691
ALSPAC
AF:
0.458
AC:
1767
ESP6500AA
AF:
0.342
AC:
1501
ESP6500EA
AF:
0.465
AC:
4003
ExAC
AF:
0.394
AC:
47781
Asia WGS
AF:
0.307
AC:
1068
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial Mediterranean fever Benign:5
Aug 18, 2011
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing;curation

Jan 14, 2015
Counsyl
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:literature only

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 19, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:4
Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MEFV: BP7, BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:3
Dec 14, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 63% of patients studied by a panel of primary immunodeficiencies. Number of patients: 60. Only high quality variants are reported.

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Familial Mediterranean fever, autosomal dominant Benign:1
Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
10
DANN
Benign
0.28
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.0023
N
LIST_S2
Benign
0.27
T
MetaRNN
Benign
0.00060
T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.21
PROVEAN
Benign
1.7
N
REVEL
Benign
0.044
Sift
Benign
1.0
T
Sift4G
Benign
0.76
T
Vest4
0.16
MutPred
0.30
Gain of MoRF binding (P = 0.0046)
ClinPred
0.0021
T
GERP RS
-0.23
Mutation Taster
=87/13
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1231122; hg19: chr16-3293888; COSMIC: COSV54819435; COSMIC: COSV54819435; API